Clinical Trials Directory

Trials / Completed

CompletedNCT00473993

Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland

Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung

Status
Completed
Phase
Study type
Observational
Enrollment
Sponsor
Seidenberg, Arztpraxis A., M.D. · Individual
Sex
All
Age
Healthy volunteers

Summary

Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to the results of the treatment of nonaddicts. Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.

Detailed description

www.seidenberg.ch/hepcop.pdf

Conditions

Timeline

Start date
2007-07-01
Completion
2007-12-01
First posted
2007-05-16
Last updated
2009-02-16

Source: ClinicalTrials.gov record NCT00473993. Inclusion in this directory is not an endorsement.